Intra-Cellular Therapies Reports First Quarter 2016 Financial Results and Provides Corporate Update

Go back to Intra-Cellular Therapies Reports First Quarter 2016 Financial Results and Provides Corporate Update

Intra-Cellular Therapies (ITCI) Tops Q1 EPS by 14c

April 28, 2016 8:42 AM EDT

Intra-Cellular Therapies (NASDAQ: ITCI) reported Q1 EPS of ($0.64), $0.14 better than the analyst estimate of ($0.78).

For earnings history and earnings-related data on Intra-Cellular Therapies (ITCI) click here.

... More